Delivery Order SPE2DB22D1106-SPE2DB24FEJY4
Award Date 4/4/24
Potential Completion Date 4/5/24
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a potential value of $1,082.68 and a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a ceiling value of $3,257.73 and a performance period through March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp...
- This is a $1,768.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 50 MG TABLET 30S, a medication, with a period of performance through May 16, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The order has a ceiling value of $3,247.98 and an ultimate completion date of June 26, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this order under an Indefinite Delivery Contract (IDC)...
- This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,134.91 firm fixed-price contract is for the delivery of 4567021601 XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency (DLA) awarded a $1,623.99 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 100 MG TABLET 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of XCOPRI 50 MG TABLET 30S, a specialty pharmaceutical product, with a potential value of $1,282.46 and a period of performance through March 6, 2024. The award was made without the use of a set-aside designation. Amerisourcebergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,899.85, is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $4,646.23 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565949010 XCOPRI 50 MG TABLET 30S. The contract has an ultimate completion date of September 27, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide pharmaceutical and medical supplies to support military...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the drug XCOPRI 50 MG TABLET 30S. The contract has a ceiling value of $1,082.68 and a period of performance ending on July 2, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...